Wen Wee Ma

机构：Cleveland Clinic, Mayo Clinic, Mayo Clinic in Florida, Case Comprehensive Cancer Center · ORCID：0000-0001-5899-4034

发表论文 364 篇 · 总被引 12026 次 · h-index 34

代表论文

• Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer (2026 · Journal for ImmunoTherapy of Cancer · 被引 9)
• Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors (2025 · JAMA Network Open · 被引 8)
• First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study (2025 · The Oncologist · 被引 7)
• Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges (2026 · MedComm · 被引 6)
• Inhaled KB707, a novel HSV-based immunotherapy, as a monotherapy in patients with advanced solid tumor malignancies affecting the lungs: Efficacy and safety results from a phase 1/2 study. (2025 · Journal of Clinical Oncology · 被引 3)
• The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation (2026 · Clinical Cancer Research · 被引 2)